Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAntalgique
2024-513404-34-00Phase 2Authorised
- Sponsor
- CEA
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetaminophen in pain, sponsored by CEA. Planned start Nov 2024; status: authorised.
02
Drugs
acetaminophen
03
Conditions
pain
Beyond the preview
Go deeper on 2024-513404-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513404-34-00.